Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants

Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants

Abstract Viruses are a major cause of mortality and socio-economic downfall despite the plethora of biopharmaceuticals designed for their eradication. Conventional antiviral therapies are often ineffective. Live-attenuated vaccines can pose a safety risk due to the possibility of pathogen reversion,...

Full description

Bibliographic Details
Main Authors: Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard, Samiramis Pourmotabed, Ehsan Nazarzadeh Zare, Ana Cláudia Paiva-Santos, Navid Rabiee, Xiangdong Wang, Franklin R. Tay
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Journal of Nanobiotechnology
Subjects:
Antiviral therapy
Delta variant
Omicron variant
SARS-CoV-2
Viral infections
Online Access:https://doi.org/10.1186/s12951-023-01938-8

Internet

https://doi.org/10.1186/s12951-023-01938-8

Similar Items